Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human FLJ39155 ELISA Kit (AC2959)
Cat.#: ASET-1548
Specifications
Description Human FLJ39155 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human FLJ39155 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.26 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1485 Rat Vaspin ELISA Kit (AC2896) Quantitative inquiry ASET-2036 Mouse ERK1 + ERK2 ELISA Kit (AC3447) Quantitative inquiry ASET-2285 Human HEXA ELISA Kit (AC3696) Quantitative inquiry ASET-1428 Sheep Myelin Basic Protein ELISA Kit (AC2839) Quantitative inquiry ASET-1122 Rat CX3CR1 ELISA Kit (AC2533) Quantitative inquiry ASET-1995 Human NRG4 ELISA Kit (AC3406) Quantitative inquiry ASET-1804 Mouse GABRA4 ELISA Kit (AC3215) Quantitative inquiry ASET-2138 Rat Relaxin 3 ELISA Kit (AC3549) Quantitative inquiry ASET-1645 Human CD24 ELISA Kit (AC3056) Quantitative inquiry ASET-2380 Human PEDF ELISA Kit (AC3791) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket